1832 Asset Management L.P. Mckesson Corp Transaction History

1832 Asset Management L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$518.81 - $607.81 $37.4 Million - $43.8 Million	72,010 Added 37900.0%	72,200 $42.2 Million
Q1 2024 May 14, 2024	BUY	$473.42 - $539.26 $89,949 - $102,459	190 New	190 $102,000
Q4 2022 Feb 14, 2023	SELL	$346.68 - $397.58 $21.4 Million - $24.5 Million	-61,729 Reduced 6.56%	879,181 $330 Million
Q3 2022 Nov 14, 2022	BUY	$321.25 - $373.84 $185 Million - $215 Million	574,797 Added 157.0%	940,910 $320 Million
Q2 2022 Aug 15, 2022	BUY	$300.57 - $336.42 $11 Million - $12.3 Million	36,657 Added 11.13%	366,113 $119 Million
Q1 2022 May 16, 2022	BUY	$244.61 - $310.48 $80.6 Million - $102 Million	329,456 New	329,456 $99.5 Million
Q4 2021 Feb 15, 2022	SELL	$198.21 - $248.9 $219,814 - $276,030	-1,109 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$188.42 - $208.66 $208,957 - $231,403	1,109 New	1,109 $229,000
Q4 2017 Feb 14, 2018	SELL	$135.02 - $162.6 $165,939 - $199,835	-1,229 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$146.0 - $161.87 $179,434 - $198,938	1,229	1,229 $183,000

1,691

108M

1.66M

968K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $82.9B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on 1832 Asset Management L.P. with notifications on news.